blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0514210

EP0514210 - GRF analogs (Growth Hormone Releasing Factors) [Right-click to bookmark this link]
Former [1992/47]GRF analogs
[1999/10]
StatusNo opposition filed within time limit
Status updated on  13.10.2000
Database last updated on 20.07.2024
Most recent event   Tooltip07.12.2007Lapse of the patent in a contracting state
New state(s): IT		published on 09.01.2008  [2008/02]
Applicant(s)For all designated states
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 North Torrey Pines Road La Jolla
California 92037 / US
[N/P]
Former [1992/47]For all designated states
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 North Torrey Pines Road
La Jolla California 92037 / US
Inventor(s)01 / Rivier, Jean Edouard Frederic
9674 Blackgold Road
La Jolla, California 92037 / US
02 / Vale, Wylie Walker, Jr.
1643 Valdez
La Jolla, California 92307 / US
[1992/47]
Representative(s)Lawrence, Malcolm Graham, et al
Avidity IP
Broers Building
Hauser Forum
21 JJ Thomson Ave
Cambridge CB3 0FA / GB
[N/P]
Former [1995/28]Lawrence, Malcolm Graham, et al
Hepworth, Lawrence, Bryer & Bizley Merlin House Falconry Court Bakers Lane
Epping Essex CM16 5DQ / GB
Former [1992/47]Lawrence, Malcolm Graham
Hepworth, Lawrence, Bryer & Bizley Merlin House Falconry Court Bakers Lane
Epping Essex CM16 5DQ / GB
Application number, filing date92304437.415.05.1992
[1992/47]
Priority number, dateUS1991070141415.05.1991         Original published format: US 701414
[1992/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0514210
Date:19.11.1992
Language:EN
[1992/47]
Type: A3 Search report 
No.:EP0514210
Date:28.04.1993
Language:EN
[1993/17]
Type: B1 Patent specification 
No.:EP0514210
Date:15.12.1999
Language:EN
[1999/50]
Search report(s)(Supplementary) European search report - dispatched on:EP12.03.1993
ClassificationIPC:C07K14/60, A61K38/25
[1999/10]
CPC:
C07K14/60 (EP,US); C07K14/00 (KR)
Former IPC [1992/47]C07K7/10, A61K37/43
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1992/47]
TitleGerman:GRF-Analoge (Growth Hormone Releasing Factors)[1992/47]
English:GRF analogs (Growth Hormone Releasing Factors)[1999/10]
French:Analogues de GRF (Growth Hormone Releasing Factors)[1992/47]
Former [1992/47]GRF analogs
Examination procedure07.10.1993Examination requested  [1993/48]
24.07.1995Despatch of a communication from the examining division (Time limit: M04)
04.12.1995Reply to a communication from the examining division
18.07.1996Despatch of a communication from the examining division (Time limit: M04)
28.11.1996Reply to a communication from the examining division
13.01.1998Despatch of a communication from the examining division (Time limit: M08)
27.07.1998Reply to a communication from the examining division
19.02.1999Despatch of communication of intention to grant (Approval: No)
21.05.1999Despatch of communication of intention to grant (Approval: later approval)
14.06.1999Communication of intention to grant the patent
13.09.1999Fee for grant paid
13.09.1999Fee for publishing/printing paid
Opposition(s)16.09.2000No opposition filed within time limit [2000/48]
Fees paidRenewal fee
27.05.1994Renewal fee patent year 03
31.05.1995Renewal fee patent year 04
30.05.1996Renewal fee patent year 05
23.05.1997Renewal fee patent year 06
01.06.1998Renewal fee patent year 07
19.05.1999Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
FR15.12.1999
GR15.12.1999
IT15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
DK15.03.2000
PT15.03.2000
DE16.03.2000
GB15.05.2000
LU15.05.2000
[2008/02]
Former [2006/14]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
FR15.12.1999
GR15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
DK15.03.2000
PT15.03.2000
DE16.03.2000
GB15.05.2000
LU15.05.2000
Former [2004/39]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
GR15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
DK15.03.2000
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
LU15.05.2000
Former [2004/07]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
GR15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
DK15.03.2000
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2003/45]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
DK15.03.2000
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2003/17]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
MC31.05.2000
Former [2003/07]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
LI15.12.1999
NL15.12.1999
SE15.12.1999
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2002/25]AT15.12.1999
BE15.12.1999
CH15.12.1999
ES15.12.1999
LI15.12.1999
SE15.12.1999
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2002/23]AT15.12.1999
BE15.12.1999
CH15.12.1999
LI15.12.1999
SE15.12.1999
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2002/11]AT15.12.1999
BE15.12.1999
CH15.12.1999
LI15.12.1999
PT15.03.2000
DE16.03.2000
FR12.05.2000
GB15.05.2000
Former [2001/17]AT15.12.1999
BE15.12.1999
CH15.12.1999
LI15.12.1999
PT15.03.2000
FR12.05.2000
GB15.05.2000
Former [2001/09]AT15.12.1999
BE15.12.1999
CH15.12.1999
LI15.12.1999
PT15.03.2000
FR12.05.2000
Former [2000/52]AT15.12.1999
BE15.12.1999
CH15.12.1999
LI15.12.1999
PT15.03.2000
Former [2000/51]AT15.12.1999
BE15.12.1999
PT15.03.2000
CH20.03.2000
LI20.03.2000
Former [2000/50]BE15.12.1999
PT15.03.2000
CH20.03.2000
LI20.03.2000
Former [2000/43]BE15.12.1999
PT15.03.2000
Documents cited:Search[XP]WO9116923  (UNIV TULANE [US])
 [X]  - Therapeutic agents produced by genetic engineering, "Quo Vadis?" Symposium, Sanofi Group, May 29-30, 1985 Toulouse-Labège, France
 [A]  - EDITORS: RIVIER ET AL 'Peptides - Proceedings of the 11th American Peptide Symposium, 1989, La Jolla, Ca., USA' 1990 , ESCOM , LEIDEN, HOLLAND
 [XP]  - EDITORS: SMITH ET AL 'Peptides - Proceedings of the 12th American Peptide Symposium, June 1991, Cambridge, Ma.,USA' 1992 , ESCOM , LEIDEN, HOLLAND
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.